Catechin can significantly reduce the expression of NF - κ B and proinflammatory mediators (IL-1 β, IL-6, TNF - α) in diabetes retinopathy rats, so it can be used as an effective component in the treatment of diabetes retinopathy. The gene discussed is IL6; the disease is diabetic retinopathy.